Freda K. Stevenson researcher
Stevenson, Freda K.
![Sudoc [ABES], France](/viaf/images/flags/SUDOC.png "Sudoc [ABES], France")
VIAF ID: 63723320 (Personal)
Permalink: http://viaf.org/viaf/63723320
Preferred Forms
-
100 0 _
‡a
Freda K. Stevenson
‡c
researcher
-
100 1 _ ‡a Stevenson, Freda K. (sparse)
-
100 1 _
‡a
Stevenson, Freda K.
-
100 1 _
‡a
Stevenson, Freda K.
-
100 1 _
‡a
Stevenson, Freda K.
4xx's: Alternate Name Forms (2)
Works
| Title | Sources |
|---|---|
| DNA vaccines & adjuvants |
|
| Immunogenetic analysis of the heavy chain variable regions of IgE from patients allergic to peanuts. |
|
| Immunogenetic analysis of the immune response to pneumococcal polysaccharide |
|
| Immunogenetic analysis reveals that epitope shifting occurs during B-cell affinity maturation in primary biliary cirrhosis |
|
| Immunogenetics of human IgE |
|
| Immunoglobulin heavy chain locus events and expression of activation-induced cytidine deaminase in epithelial breast cancer cell lines |
|
| Immunoglobulin produced by guinea-pig leukaemic B lymphocytes: its source and use as a monitor of tumour load |
|
| Immunoglobulin VH gene sequence analysis of spontaneous murine immunoglobulin-secreting B-cell tumours with clinical features of human disease |
|
| Immunotherapy of hematologic malignancy. |
|
| In situ vaccination with a TLR9 agonist induces systemic lymphoma regression: a phase I/II study |
|
| Incidence of novel N-glycosylation sites in the B-cell receptor of lymphomas associated with immunodeficiency. |
|
| Inhibition of a vaccine-induced anti-tumor B cell response by soluble protein antigen in the absence of continuing T cell help |
|
| Initial experience in treating human lymphoma with a chimeric univalent derivative of monoclonal anti-idiotype antibody |
|
| Insight into the origin and clonal history of B-cell tumors as revealed by analysis of immunoglobulin variable region genes |
|
| Insight into the potential for DNA idiotypic fusion vaccines designed for patients by analysing xenogeneic anti-idiotypic antibody responses |
|
| Interactive health communication applications for chronic disease: Patient and carer perspectives |
|
| Introduction: immunotherapy for multiple myeloma--insights and advances |
|
| Introduction to a review series on advances in cell-based immune therapeutics in hematology |
|
| Introduction to a review series on biological insights into lymphoid tumors |
|
| Introduction to a review series on understanding and treating primary immunodeficiency |
|
| Intronic BCL-6 mutations are preferentially targeted to the translocated allele in t(3;14)(q27;q32) non-Hodgkin B-cell lymphoma |
|
| Involvement of innate and induced anti-idiotypic mechanisms in suppression of B cell tumors |
|
| Isolation and EBV-transformation of a minor population of normal human tonsillar B cells bearing a cold agglutinin-associated idiotope |
|
| Isotype switch variants reveal clonally related subpopulations in diffuse large B-cell lymphoma |
|
| Lectin binding to surface Ig variable regions provides a universal persistent activating signal for follicular lymphoma cells. |
|
| Lineage complexity in multiple myeloma? |
|
| Linear doggybone DNA vaccine induces similar immunological responses to conventional plasmid DNA independently of immune recognition by TLR9 in a pre-clinical model. |
|
| Linked CD4 T Cell Help: Broadening Immune Attack Against Cancer by Vaccination |
|
| Lymphokine-activated killer cells from normal and lymphoma subjects are cytotoxic for cells coated with antibody derivatives displaying human Fc gamma |
|
| Lymphoma in Sjögren's syndrome: urinary monoclonal free light chains as a diagnostic aid and a means of tumour monitoring |
|
| Mantle cell lymphoma with t(11;14) and unmutated or mutated VH genes expresses AID and undergoes isotype switch events |
|
| Measuring the appropriateness of prescribing in primary care: are current measures complete? |
|
| Mechanisms and clinical significance of BIM phosphorylation in chronic lymphocytic leukemia. |
|
| Mediation of cytotoxic functions by classes and subclasses of sheep antibody reactive with cell surface immunoglobulin idiotypic and constant region determinants |
|
| Molecular characterization of a cross-reactive idiotope on human immunoglobulins utilizing the VH4-21 gene segment |
|
| Molecular vaccines in infection and cancer |
|
| Monoclonal anti-light chain idiotype as a tumor-specific probe for human neoplastic B lymphocytes |
|
| Monoclonal antibodies raised against the idiotype of the murine B cell lymphoma, BCL1 act primarily with heavy chain determinants |
|
| Monoclonal immunoglobulin light chain in urine of patients with B lymphocytic disease: its source and use as a diagnostic aid. |
|
| Myeloma VL and VH gene sequences reveal a complementary imprint of antigen selection in tumor cells. |
|
| New strategies for vaccination and imunomodulation in NHL. |
|
| Nucleotide sequence analysis of the V regions of two IgM cold agglutinins. Evidence that the VH4-21 gene segment is responsible for the major cross-reactive idiotype |
|
| Optimizing cancer immunotherapy trials: back to basics. |
|
| Origins of the malignant clone in typical Waldenstrom's macroglobulinemia |
|
| PASD1 is a potential multiple myeloma-associated antigen |
|
| Pattern of usage and somatic hypermutation in the V(H)5 gene segments of a patient with asthma: implications for IgE. |
|
| Pattern of usage of the VH4–21 gene by B lymphocytes in a patient with EBV infection indicates ongoing mutation and class switching |
|
| Patterns of somatic mutations in VH genes reveal pathways of clonal transformation from MGUS to multiple myeloma. |
|
| PEITC-mediated inhibition of mRNA translation is associated with both inhibition of mTORC1 and increased eIF2α phosphorylation in established cell lines and primary human leukemia cells. |
|
| Peripheral blood stem cell autografts in myeloma |
|
| Phage surface expression for analysis of recognition sites of human autoantibodies: comparison of single chain Fv and Fab. |
|
| Pharmacological inhibitors of NF-κB accelerate apoptosis in chronic lymphocytic leukaemia cells |
|
| Phenotypic heterogeneity in IGHV-mutated CLL patients has prognostic impact and identifies a subset with increased sensitivity to BTK and PI3Kδ inhibition |
|
| A pilot study of idiotypic vaccination for follicular B-cell lymphoma using a genetic approach. CRC NO: 92/33. Protocol NO: PH1/027. |
|
| A plant-expressed conjugate vaccine breaks CD4(+) tolerance and induces potent immunity against metastatic Her2(+) breast cancer |
|
| Plant viral genes in DNA idiotypic vaccines activate linked CD4+ T-cell mediated immunity against B-cell malignancies |
|
| Plant virus particles carrying tumour antigen activate TLR7 and Induce high levels of protective antibody |
|
| PML-RARA-targeted DNA vaccine induces protective immunity in a mouse model of leukemia. |
|
| Polycythemia rubra vera and hairy cell leukemia |
|
| Preclinical Evaluation of a Novel SHIP1 Phosphatase Activator for Inhibition of PI3K Signaling in Malignant B Cells |
|
| Preliminary experience in treating lymphocytic leukaemia with antibody to immunoglobulin idiotypes on the cell surfaces |
|
| Preliminary studies for an immunotherapeutic approach to the treatment of human myeloma using chimeric anti-CD38 antibody |
|
| Preparation and properties of FabIgG, a chimeric univalent antibody designed to attack tumour cells |
|
| Preparing the ground for vaccination against multiple myeloma |
|
| Primary central nervous system lymphoma: tumor-related clones exist in the blood and bone marrow with evidence for separate development |
|
| Prime-Boost with Alternating DNA Vaccines Designed to Engage Different Antigen Presentation Pathways Generates High Frequencies of Peptide-Specific CD8+ T Cells |
|
| Problems and prospects in the use of lymphoma idiotypes as therapeutic targets |
|
| Prolonged antigen expression following DNA vaccination impairs effector CD8+ T cell function and memory development |
|
| Prospects for the treatment of B cell tumors using idiotypic vaccination |
|
| Protein-polysaccharide complexes secreted by the calf tracheal epithelium in vitro |
|
| Proteomic analysis of chronic lymphocytic leukemia subtypes with mutated or unmutated Ig V(H) genes |
|
| Public T cell receptor beta-chains are not advantaged during positive selection |
|
| Quantitative determination of xylose in mucopolysaccharide derivatives |
|
| Rapid cytotoxicity of human B lymphocytes induced by VH4-34 (VH4.21) gene-encoded monoclonal antibodies, II. |
|
| Recognition of a B cell lymphoma by anti-idiotypic T cells |
|
| Recognition of auto- and exoantigens by V4-34 gene encoded antibodies |
|
| Remarkable selective glycosylation of the immunoglobulin variable region in follicular lymphoma |
|
| Reversible anergy of sIgM-mediated signaling in the two subsets of CLL defined by VH-gene mutational status |
|
| Revisiting the definition of somatic mutational status in B-cell tumors: does 98% homology mean that a V(H)-gene is unmutated? |
|
| Secretion of idiotypic IgM by the mouse B-cell leukaemia (BCL1) occurs spontaneously in vitro and in vivo |
|
| Secretion of immunoglobulin by neoplastic B lymphocytes from lymph nodes of patients with lymphoma |
|
| Selective expression of a VHIV subfamily of immunoglobulin genes in human CD5+ B lymphocytes from cord blood |
|
| Sequence analysis of immunoglobulin variable region genes that encode autoantibodies expressed by lymphomas of mucosa associated lymphoid tissue. |
|
